U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Public Health Strategy and Analysis Staff
  1. Office of Economics and Analysis

Public Health Strategy and Analysis Staff

Dr. Harinder S. Chahal, PharmD, MSc., PHSA Staff Director

The Public Health Strategy & Analysis (PHSA) Staff leads and undertakes initiatives and research on issues of priority to FDA leadership, and provides leadership, strategic thinking, and management, on all Government Accountability Office (GAO) and HHS Office of Inspector General (OIG) audits and studies of FDA.

PHSA acts as an Office of the Commissioner and Agency resource for qualitative and quantitative research and analysis on emerging issues, including helping to develop policy options and understanding the expected impact of those options on public health outcomes.  To achieve these functions the staff is divided into two teams: Public Health Initiatives Team and GAO/OIG Liaison Team.

Find more about job opportunities, fellowships, and internships with PHSA here.

Leadership

Dr. Harinder S. Chahal, PharmD, MSc.
PHSA Staff Director

Dr. Chahal is the staff director for the Public Health Strategy and Analysis (PHSA) staff in the Office of Economics and Analysis. Dr. Chahal has led a variety of cross-agency initiatives at FDA including developing analytical tools to assist in opioid response, creating de-novo tools to efficiently process of dockets and comments, and serving as the US chair for a multinational World Health Organization’s workgroup to combat proliferation of substandard and falsified medical products in informal markets. In collaboration with Center-based stakeholders, Dr. Chahal has led multiple quantitative public health research projects on topics such as impact of generic competition on drug access and affordability, and transparency of regulatory decision making. He joined the FDA as an International Affairs fellow in FDA’s (formerly known as) Office of International Programs, before transitioning to PHSA. He previously served as the Team Lead for the Public Health Initiatives team in PHSA.

Education: B.A. in Political Science and B.S. in Biological Sciences from University of California, Davis; PharmD and MSc in Global Health from University of California, San Francisco.

Contact Us

For more information, please contact PHSA at OPHSA@fda.hhs.gov.

 

 



Back to Top